Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis.

Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis. — المؤلف: Santofimia-Castaño, Patricia — The Journal of clinical investigation 20200413

المؤلف
Santofimia-Castaño, Patricia
النشر
The Journal of clinical investigation 20200413
الوصف
2500-2513 p.
الموضوعات
Animals؛ Antineoplastic Agents؛ Basic Helix-Loop-Helix Transcription Factors؛ Hep G2 Cells؛ Humans؛ Jurkat Cells؛ Mice؛ Mice, Nude